A UBS report says major new US AI regulation is unlikely despite AI becoming a central issue in the midterm elections, and a light-touch approach is likely to persist, partly because AI is expected to boost long-term economic growth through higher productivity. UBS estimates that capital expenditure by hyperscalers will reach nearly 2% of US GDP in 2026, and that AI investment and the wealth effect from rising equity prices together contributed around 100 basis points to the 2.4% economic growth in the first half of 2026. The report also notes that in October 2026 President Trump announced a voluntary agreement with six major tech companies, including OpenAI and Anthropic, focused on internal safety controls, monitoring and independent assessments, without legally enforceable requirements.
Summary written by Upside AI from the original article. Read the source for full details.
Original headline: Major new US regulation on AI unlikely despite rising political focus : UBS Report
Read the original on aninews.in ↗
Keywords
artificial intelligenceregulationmidterm electionsGDP growth
Open a keyword to see other news on the same topic.
Related tickers and likely impact
MSFT
▲ Likely positiveMicrosoft
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Systems Software |
| Market cap | $4.0T |
| Close on 10/21/2026 | 532.81 |
| Change that session | +0.18% |
NVDA
▲ Likely positiveNvidia
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductors |
| Market cap | $5.2T |
| Close on 10/21/2026 | 221.87 |
| Change that session | +2.49% |
QQQ
▲ Likely positiveInvesco QQQ Trust
Relevance: low
| Market | US stocks |
|---|---|
| Sector | ETF |
| Close on 10/21/2026 | 725.21 |
| Change that session | +1.06% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Major new US regulation on AI unlikely despite rising political focus : UBS Report
UBS says major new US regulation on artificial intelligence is unlikely, even though AI has become a central issue in the midterm elections, and a light-touch approach will likely persist. Part of the reason is the expectation that AI will boost long-term US economic growth. Capital expenditure by major cloud companies, known as hyperscalers, is projected to reach nearly 2 per cent of US GDP in 2026. UBS estimated that AI investment and the wealth effect from rising equity prices together added around 100 basis points to growth in the first half of 2026, when the economy grew 2.4 per cent. In October, President Trump announced a voluntary agreement with 6 major technology companies, including OpenAI and Anthropic, covering internal safety controls, monitoring and independent assessments, but it is not legally enforceable.
- Fact check: When it comes to Trump economy, these numbers matter
An AP fact check ahead of the November 3 midterm elections finds the U.S. economy is neither as strong as President Trump claims nor as weak as consumer surveys suggest. Inflation was 3.7% over the past 12 months in the last CPI report before Election Day, rising again after tariffs were announced in April 2025 and the Iran war pushed up gasoline prices. GDP has grown a little over 2% annually under Trump and unemployment is 4.2%, but job growth has averaged almost 39,000 a month this term versus more than 121,000 in the prior year. The 10-year Treasury yield is above 5%, its highest since 2002, while the S&P 500 is up about 12% this year. Federal Reserve data show the top 0.1% of households gained $5.5 trillion in wealth in 18 months, while the bottom half of households saw their net worth rise by $5,600 on average.
- FACT FOCUS : When it comes to Trump economy , these are the numbers that matter before Nov . 3
- Moore , Crosby spar over economy and growth at Congressional District 2 debate
- The banking safety net : Protecting deposits and safeguarding economic growth
- Crypto Super PAC Fairshake Pours Millions More Into Defeating Sherrod Brown
Crypto super PAC Fairshake has reported fresh spending to defeat Democratic Sen. Sherrod Brown in Ohio, pushing its total against him past $40 million. A Federal Election Commission filing signed Oct. 15 shows affiliate Defend American Jobs disclosed a $5.2 million media buy against Brown, another roughly $1.95 million days later, plus production costs, bringing his calendar-year total to about $46.66 million, the most expensive 2026 target for the industry. The same filing shows parallel spending supporting his Republican opponent Jon Husted. The move follows Fairshake's Oct. 5 announcement backing 32 House incumbents, with an initial $6 million committed to six of them. Brown, a longtime crypto critic who chaired the Senate Banking Committee, lost his seat in 2024 after Fairshake spent roughly $40 million to help defeat him.
Related markets
Latest news
- Sranan Gold Reports 3-Metre Channel Sample Grading 20.89 g/t Gold at Lawatino's 101 Zone
Sranan Gold Corp. (CSE: SRAN) reported additional high-grade gold assays from ongoing trenching and channel sampling at the 101 Zone on its 18,468-hectare Lawatino Gold Project in southeastern Suriname. A 3-metre channel interval in trench 26LACH-008 graded 20.89 g/t Au, including a 1-metre sample at 55.04 g/t Au, while grab samples returned up to 57.58 g/t Au. The company is mapping a roughly 1.5-kilometre northwest-southeast trend between the 101 and Bodoe Zones ahead of a planned Phase I drill program in early 2027. Management noted that grab samples are selective and may not represent average grades, and that the true widths of the mineralization are not yet known.
- Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?
The article compares revenue growth at Bristol Myers Squibb and Eli Lilly. Lilly's growth is driven by GLP-1 drugs: Mounjaro brought in $9.9 billion worldwide in Q2 (up 91% year over year), Zepbound $4.9 billion in U.S. sales, and the oral Foundayo, launched in April 2026, $98 million in its first quarter. Bristol Myers Squibb (BMY) has steadier revenue, with no GLP-1 drug on the market and reliance on Eliquis and Opdivo, and its growth portfolio made up 58% of Q2 revenue. The article notes Bristol Myers Squibb trades at about 9.4 times forward earnings versus almost 25 times for Lilly, and says Lilly's two main products account for nearly two-thirds of quarterly sales, a concentration and pricing risk to its growth. Both companies report third-quarter results on Oct. 29.
- American Airlines expects deeper 2026 loss on pricier fuel despite record revenue
American Airlines now expects to lose between $1 and $1.60 per share on an adjusted basis for the full year, a deeper loss as fuel costs spiked and offset record revenue. In the third quarter it reported an adjusted loss of 28 cents per share versus 35 cents expected by analysts compiled by LSEG, and revenue of $16.34 billion versus $16.22 billion expected. CEO Robert Isom said the company delivered record third-quarter revenue and expects another quarter of record revenue growth to close out the year.
- Replit Expands Government Business Worldwide, Taps Former Amazon Executive to Lead Corporate Affairs
Replit announced an expansion of its government business, saying it is seeing strong adoption by agencies at the national, state and local levels in the U.S. and overseas, including the Middle East. It also appointed Michael Greenwald, a former U.S. Treasury diplomat and AWS executive, as President of Corporate Affairs to accelerate its push into the public sector. Greenwald previously served as Director of Global Executive Relations at AWS and as Managing Director at AlTi Global, and spent nearly a decade at the U.S. Treasury, including as the first U.S. Treasury attaché to Qatar and Kuwait. The company says that once a single department uses Replit, its business doubles after six months and grows 400% over 12 months, and that its platform is used by 85% of Fortune 500 companies.
- Should You Forget ExxonMobil and Buy Cameco Stock Instead?
The article argues that Cameco may be a better buy than ExxonMobil, whose stock has surged over 47% since the start of the year as Brent crude stays above $100 per barrel, while Cameco's stock is down 11%. Exxon trades at 13.3 times forecast earnings, while Cameco's forward P/E is 45, though analysts project Exxon's earnings per share at around $13.23 this year, up 90% from last year. Cameco has contracts for roughly 28 million pounds of yellowcake per year and a large uncommitted volume for 2029 and 2030 that could help it lock in higher prices as uranium demand grows. Bank of America projects spot uranium could reach $130 per pound, and if prices stay near $100, Cameco's average realized price could rise to $80 from $67.79 in Q2, which the article says would lift earnings faster than analysts expect.
- David's Bridal plans to spin off others AI platform Pearl into publicly traded company
David's Bridal plans to spin off its AI platform Pearl into a stand-alone public company valued at roughly $350 million, with the deal expected to close in the first half of 2027. Pearl will own the company's intellectual property and license it back to the chain, while CEO Kelly Cook will lead Pearl after closing. Pearl expects an EBITDA margin above 30% this year and revenue growth of more than 100% in 2027, exceeding $85 million, and is expected to be debt-free with positive free cash flow over the next two years. Cion Investment Corp., which bought the business after David's Bridal's second bankruptcy filing in 2023, has proposed investing $25 million as an anchor investor in the separate company, amid struggling AI stocks and a lackluster consumer IPO market.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.